ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Erbitux 100 mg/20 ml, Infusionslösung - 20 ml
56072003 Merck (Schweiz) AG
Erbitux 100 mg/20 ml, Infusionslösung01.12.2003
  01.10.2007
(L01FE01)01.10.2007
WHO-DDD 
07.16.10.20 ml
07.16.10. 
A  
Yes 
IPCI
187.45Yes
    
10 %220.30
  
7680560720032Biotechnologika
3686417 
Composition
cetuximabum 100 mg, natrii chloridum, glycinum, polysorbatum 80, acidum citricum monohydricum, natrii hydroxidi solutio 1 mol/L, aqua ad iniectabile q.s. ad solutionem pro 20 ml corresp. natrium 58 mg.
Packungsbestandteile
Infusion solution 
  
 
Active AgentDose
Cetuximab100mg / 20ml
BAG: Active AgentDose
Cetuximab100 mg
 
Inactive agentsDose
Citric Acid Monohydrate 
Glycin 
Mol/l 
Sodium Chloride 
Natrii Hydroxidi Solutio1
Polysorbatum 80 
 
Source
Data was imported : 14.04.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home